Enhancing Infrastructure for Development and Analysis of Regenerative Cell Therapies

LEAH Labs is an innovative biotech startup headquartered at Mayo Clinic's 'Hatchery Lab' developing regenerative cell therapies, first focused on cancer and autoimmune disease in dogs. Not only is there an unmet need for biotech innovation for our furry family members, but they are also afflicted by the same types of diseases as humans. At LEAH Labs, we aim to develop therapies that can help our pets while also informing human regenerative cell therapy trials. In this proposal, we are requesting capital for a flow cytometer that will help us expand our in-house infrastructure for development and analysis of regenerative cell therapies for dogs and their humans.